CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,085,000 | -94.4% | 146,135 | -91.4% | 0.02% | -94.3% |
| Q1 2021 | $36,957,000 | +31.9% | 1,702,308 | -8.1% | 0.42% | +44.4% |
| Q4 2020 | $28,012,000 | +15.5% | 1,851,443 | -2.8% | 0.29% | +2.1% |
| Q3 2020 | $24,250,000 | -31.3% | 1,905,680 | -7.7% | 0.29% | -41.2% |
| Q2 2020 | $35,314,000 | +49.6% | 2,065,153 | +15.6% | 0.49% | +21.1% |
| Q1 2020 | $23,607,000 | +61.3% | 1,787,062 | +96.7% | 0.40% | +105.6% |
| Q4 2019 | $14,637,000 | +113.6% | 908,570 | +142.3% | 0.20% | +127.9% |
| Q3 2019 | $6,854,000 | -51.2% | 374,948 | -42.6% | 0.09% | -50.6% |
| Q2 2019 | $14,034,000 | +64.8% | 652,742 | +50.4% | 0.17% | +75.8% |
| Q1 2019 | $8,514,000 | +64.5% | 433,967 | +9.0% | 0.10% | +26.9% |
| Q4 2018 | $5,177,000 | -56.8% | 398,196 | -20.5% | 0.08% | -23.5% |
| Q3 2018 | $11,989,000 | +3.6% | 500,581 | -17.2% | 0.10% | +18.6% |
| Q2 2018 | $11,572,000 | – | 604,272 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |